HCQ shows no benefit against early, mild Covid-19: Study
New York: Researchers have shown that the famous anti-malarial drug hydroxychloroquine (HCQ) was ineffective for Covid-19 patients with early and mild...
New York: Researchers have shown that the famous anti-malarial drug hydroxychloroquine (HCQ) was ineffective for Covid-19 patients with early and mild...
London: Researchers have now discovered that the concentration of the two drugs -- Lopinavir and hydroxychloroquine (HCQ) -- in the...
New Delhi: India on Thursday lifted the restriction on the export of anti-malarial drug Hydroxychloroquine, which is widely used around...
New Delhi: The World Health Organisation on Wednesday said that anti-malarial drug hydroxychloroquine (HCQ) will return to the solidarity trial for...
New Delhi: NITI Aayog member V.K. Paul, here on Thursday, said the Indian Council of Medical Research (ICMR) had recommended...
Geneva: After a large scale study flagged that hydroxychloroquine (HCQ) offers no benefit to patients affected by coronavirus, the World...
New Delhi: The Indian Council of Medical Research (ICMR) has issued revised guidelines for use of hydroxychloroquine (HCQ), the malaria...
London: Hydroxychloroquine (HCQ), an anti-malarial drug termed potential "game-changer" for COVID-19 by President Donald Trump, does not significantly reduce admission...
Three weeks after Prime Minister Narendra Modi, President Ram Nath Kovind and Prime Minister's Office (PMO) was followed by The...
Washington: At a time when hydroxychloroquine (HCQ) is being touted as a 'wonder drug' to treat critical Covid-19 patients, the US...